Ventricular fibrillation

(M-4) are both excreted in the urine, with a clearance approximately 50% that of total body clearance. Clinical Trials: ENGAGE AF-TIMI 48 ClincalTrials.gov Identifier: NCT00781391 Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 This Phase 3 clinical…

symptomatic atrial fibrillation. Physicians in the ER stated that patient Afib probably had had atrial fibrillation for a while, but it had been exacerbated for an unknown reason. The emergency room physician advised patient Afib to visit a cardiologist to figure out why the arrhythmia had begun and how to fix it. After consultation with a cardiologist and a sleep study,…

She has atrial fibrillation, history of coronary artery disease, status post intervention back in 2004 with a CABG. She is feeling well from that standpoint. She is not having any chest pain. She is not having shortness of breath. She does have hypertension. She is taking…

wasn’t sure what to expect, but I hoped for the best. For my primary patient, I had a 59-year-old female who was admitted with a diagnosis of atrial fibrillation. She was an independent patient and who did well being at home without complications. As I listened to the report with my nurse, I was able to note that my patient has dealt with atrial fibrillation symptoms before and she was able to handle how she felt before. She could tell when her heart rate was fast and she could control it but…

action of a medication in the body is study, which includes the process of absorption, distribution, metabolism and elimination (Edmunds, 2014). The patient that currently being cared for is a 73 year old female with past medical history of atrial fibrillation, kidney dysfunction and diabetes mellitus. Currently the patient takes the following medications: Pravastatin 10 mg, Lisinopril 2.5 mg, Digoxin 0.125 mg, Warfarin 7.5 mg, HCTZ 25 mg, all of which are taken orally and daily. She also takes…

Atrial fibrillation (AF) is typically a supraventricular tachyarrhythmia which is known for having an uncoordinated atrial activation resulting in worsening of atrial mechanical function. (1) AF is very common and presents around one-third of hospital admissions due to cardiac rhythm disturbances. There has been a substantial increase in hospital admission for AF which can be the result of an aging of the population and an increase in prevalence chronic heart disease.(2–4) Nonvalvular AF is…

Atrial Fibrillation One of the most common arrhythmias that clinicians will confront in practice is Atrial Fibrillation (AF). The incident of AF increases with age. Many patients with AF are asymptomatic and only diagnosed incidentally. Many others experience only non-specific symptoms such as palpitations, dyspnea, or chest pain. The following case study illustrates the clinical role of the advanced practice nurse in the assessment of a patient presenting with Atrial Fibrillation. Jimmy J….a…

In order to understand exactly what Left Ventricular Hypertrophy is, it is important to be able to break down the word. The prefix Hyper- means over or more, and the suffix -trophy means well-fed. Therefore, LVH is the thickening and/ or the enlargement of the left ventricle. Under normal conditions, the left ventricle of the heart is responsible for the big push that sends blood through the aorta and to the rest of the body (Sheir 2015, p.560). When the left ventricle becomes thickened, or…

Diagram the ventricular system. Be certain to include: the lateral ventricles, the 3rd and 4th ventricles, the cerebral aqueduct, and the central canal. Describe the purpose of the ventricular system. In your answer be certain to define components of this system that are more difficult the diagram; specifically Cerebral Spinal Fluid and Arachnoid granulations. (10 points) The ventricular system is made up of ventricles in the brain which contain…

A growing number of non-cardiac drugs have been found to delay cardiac repolarization, causing QT interval prolongation and predisposing patients to an increased risk of potentially fatal ventricular arrhythmias, known as torsade de pointes (TdP) (Letsas et al, 2007; Yap and Camm 2003; Sanguinetti and Tristani-Firouzi). These drugs include the second-generation, non-sedating antihistamines astemizole and terfenadine, withdrawn from the market in Europe and the United States (in 1997 and 1999,…